NowPatient
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
- Semaglutide
- $1,349/mo (brand Wegovy)
- Tirzepatide
- $1,069/mo (brand Mounjaro, promotional rate)
- Coverage
- Coverage not published
- Brand-name
- Yes
Weigh NowPatient against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
What to consider
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Bottom line — Grade C
Best for: Shoppers who want brand-name GLP-1 access without a compounded route.
Site position #243 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest NowPatient — the realistic shortlist.
Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.
Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at $199/month.
Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.
Shapely is a GLP-1 telehealth platform founded by Dr. Justin Zaghi, MD/MBA, a Harvard-trained physician board-certified in both internal medicine and obesity medicine.
Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and Zepbound (tirzepatide), alongside dietitian counseling, health coaching, metabolic testing, and behavioral support.
RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr. Michael Wasef, MD, licensed in all 50 states) offering compounded semaglutide and tirzepatide for weight loss, including microdose entry options.
The 19 rankings nearest this one
- #249 Roboclinic65.3
- #250 Dr. Arevitalize65.2
- #251 Mixx Health & Wellness65.2
- #252 Southern Vitality and Weight Loss65.2
- #253 Intimate Rose65.1
- #254 Vital Edge65
- #255 BetterMe Rx64.9
- #256 Livv64.9
- #257 QuickMD64.9
- #258 Vita Bella64.9
- #259 Better U Care64.8
- #260 NEUVÉ Health64.7
- #261 Rylo Health64.7
- #262 Injectco64.6
- #263 Lumen Meds64.6
- #264 LevelUp Rx64.4
- #265 PeptidesRx64.4
- #266 Tru2u64.4
- #267 Whoosh Wellness64.4
Pricing/verification reflect NowPatient's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.